ClearPoint Neuro, Inc. (CLPT) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$10.09M*; Operating income -$10.24M; Depreciation and amortization $150.00K*.
- 2026-03-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$5.21M*; Operating income -$5.28M; Depreciation and amortization $66.00K*.
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | -$10.09M* | -$10.24M | $150.00K* | $10.88M | -92.78%* | $214.00K* | -$7.01M* | (m) | $4.63M | $5.55M | -$38.00K |
| 2026-03-31 | Reported | (m) | (m) | (m) | (m) | -69.20% | $645.00K | -$7.97M | (m) | $4.52M | $5.00M | $8.00K |
| 2025-12-31 | Reported | (m) | (m) | (m) | (m) | -65.28% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | Reported | -$5.21M* | -$5.28M | $66.00K* | $8.86M | -58.80%* | $199.00K* | -$3.12M* | (m) | $3.45M | $3.59M | $8.00K |
| 2025-06-30 | Reported | -$5.28M* | -$5.68M | $396.00K* | $9.21M | -57.34%* | $91.00K* | -$2.55M* | (m) | $3.83M | $3.39M | $25.00K |
| 2025-03-31 | Reported | (m) | (m) | (m) | (m) | -71.42% | $183.00K | -$6.17M | (m) | $3.38M | $4.08M | $18.00K |
| 2024-12-31 | Reported | (m) | (m) | (m) | (m) | -69.44% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | Reported | -$4.89M* | -$5.16M | $264.00K* | $8.12M | -60.26%* | $12.00K* | -$1.20M* | (m) | $3.31M | $3.14M | $14.00K |
| 2024-06-30 | Reported | -$4.49M* | -$4.72M | $233.00K* | $7.86M | -57.15%* | $0.00* | -$2.67M* | (m) | $3.12M | $2.76M | $15.00K |
| 2024-03-31 | Reported | (m) | (m) | (m) | (m) | -52.01% | $0.00 | -$3.84M | (m) | $2.63M | $2.83M | $15.00K |
| 2023-12-31 | Reported | (m) | (m) | (m) | (m) | -66.42% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | Reported | -$4.74M* | -$4.90M | $158.00K* | $5.76M | -82.25%* | $235.00K* | -$1.80M* | (m) | $2.43M | $2.90M | (m) |
| 2023-06-30 | Reported | -$6.97M* | -$7.13M | $156.00K* | $5.95M | -117.23%* | $323.00K* | -$5.08M* | (m) | $3.60M | $3.18M | (m) |
| 2023-03-31 | Reported | (m) | (m) | (m) | (m) | -102.76% | $138.00K | -$5.68M | (m) | $3.02M | $2.96M | (m) |
| 2022-12-31 | Reported | (m) | (m) | (m) | (m) | -85.99% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | Reported | -$3.76M* | -$3.79M | $37.00K* | $5.15M | -73.03%* | $69.00K* | -$3.85M* | (m) | $2.65M | $2.40M | (m) |
| 2022-06-30 | Reported | -$4.10M* | -$4.20M | $101.00K* | $5.20M | -78.90%* | $76.00K* | -$4.98M* | (m) | $2.41M | $2.66M | (m) |
| 2022-03-31 | Reported | (m) | (m) | (m) | (m) | -75.09% | $69.00K | -$4.27M | (m) | $2.90M | $2.18M | (m) |
| 2021-12-31 | Reported | (m) | (m) | (m) | (m) | -91.92% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | Reported | -$3.75M* | -$3.80M | $51.00K* | $4.57M | -82.05%* | $125.00K* | -$3.30M* | (m) | $2.60M | $2.44M | (m) |
| 2021-06-30 | Reported | -$3.36M* | -$3.41M | $47.00K* | (m) | (m) | -$35.00K* | -$3.72M* | (m) | $2.11M | $1.98M | (m) |
| 2021-03-31 | Reported | (m) | (m) | (m) | (m) | -53.75% | $40.00K | -$2.13M | (m) | $1.56M | $1.66M | (m) |
| 2020-12-31 | Reported | (m) | (m) | (m) | (m) | -56.54% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | Reported | -$1.22M* | -$1.27M | $54.00K* | (m) | (m) | (m) | -$1.37M* | (m) | $1.14M | $1.25M | (m) |
| 2020-06-30 | Reported | -$1.42M* | -$1.48M | $58.00K* | (m) | (m) | (m) | -$1.71M* | (m) | $812.00K | $1.21M | (m) |
| 2020-03-31 | Reported | (m) | (m) | (m) | (m) | -36.94% | (m) | -$2.33M | (m) | $818.00K | $1.28M | (m) |
| 2019-12-31 | Reported | (m) | (m) | (m) | (m) | -42.96% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | Reported | -$874.82K* | -$910.53K | $35.71K* | (m) | (m) | (m) | -$964.13K* | (m) | $761.88K | $1.03M | (m) |
| 2019-06-30 | Reported | -$1.26M* | -$1.29M | $34.96K* | (m) | (m) | (m) | -$810.11K* | (m) | $697.80K | $1.03M | (m) |
| 2019-03-31 | Reported | (m) | (m) | (m) | (m) | -37.92% | (m) | -$609.46K | (m) | $584.54K | $933.03K | (m) |
| 2018-12-31 | Reported | (m) | (m) | (m) | (m) | -41.77% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | Reported | -$1.18M* | -$1.21M | $25.79K* | (m) | (m) | $11.15K* | -$975.27K* | (m) | $617.24K | $1.08M | (m) |
| 2018-06-30 | Reported | -$1.61M* | -$1.64M | $23.80K* | (m) | (m) | $30.85K* | -$1.11M* | (m) | $665.31K | $1.09M | (m) |
| 2018-03-31 | Reported | (m) | (m) | (m) | (m) | -85.96% | $20.65K | -$1.96M | (m) | $546.33K | $952.95K | (m) |
| 2017-12-31 | Reported | (m) | (m) | (m) | (m) | -107.71% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | Reported | -$1.30M* | -$1.33M | $26.83K* | (m) | (m) | $21.38K* | -$1.68M* | (m) | $589.72K | $866.73K | (m) |
| 2017-06-30 | Reported | -$1.79M* | -$1.82M | $29.70K* | (m) | (m) | (m) | -$1.22M* | (m) | $1.08M | $935.70K | (m) |
| 2017-03-31 | Reported | (m) | (m) | (m) | (m) | -65.64% | (m) | -$1.35M | (m) | $557.70K | $984.27K | (m) |
| 2016-12-31 | Reported | (m) | (m) | (m) | (m) | -107.62% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | Reported | -$1.67M* | -$1.71M | $36.40K* | (m) | (m) | $0.00* | (m) | (m) | $691.33K | $1.89M | (m) |
| 2016-06-30 | Reported | -$2.01M* | -$2.06M | $47.66K* | (m) | (m) | $22.68K* | (m) | (m) | $749.94K | $1.89M | (m) |
| 2016-03-31 | Reported | (m) | (m) | (m) | (m) | -135.77% | $77.65K | (m) | (m) | $657.19K | $1.97M | (m) |
| 2015-12-31 | Reported | (m) | (m) | (m) | (m) | -90.06% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | Reported | -$1.91M* | -$1.93M | $16.19K* | (m) | (m) | $64.64K* | (m) | (m) | $480.28K | $2.13M | (m) |
| 2015-06-30 | Reported | -$2.63M* | -$2.68M | $50.68K* | (m) | (m) | $742.00* | (m) | (m) | $426.93K | $2.19M | (m) |
| 2015-03-31 | Reported | (m) | (m) | (m) | (m) | -282.87% | $6.63K | -$2.80M | (m) | $527.51K | $2.29M | (m) |
| 2014-12-31 | Reported | (m) | (m) | (m) | (m) | -270.47% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | Reported | -$2.53M* | -$2.62M | $88.56K* | (m) | (m) | $6.21K* | -$2.18M* | (m) | $873.37K | $2.06M | (m) |
| 2014-06-30 | Reported | -$2.10M* | -$2.22M | $113.45K* | (m) | (m) | $2.99K* | -$1.72M* | (m) | $898.42K | $1.93M | (m) |
| 2014-03-31 | Reported | (m) | (m) | (m) | (m) | 277.76% | $2.39K | -$1.36M | (m) | $817.62K | $1.80M | (m) |
| 2013-12-31 | Reported | (m) | (m) | (m) | (m) | -169.00% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | Reported | -$1.75M* | -$1.86M | $114.81K* | (m) | (m) | $17.80K* | -$1.84M* | (m) | $725.30K | $1.70M | (m) |
| 2013-06-30 | Reported | -$2.06M* | -$2.18M | $116.80K* | (m) | (m) | $47.86K* | -$2.19M* | (m) | $741.82K | $1.70M | (m) |
| 2013-03-31 | Reported | (m) | (m) | (m) | (m) | -99.07% | $7.99K | -$2.24M | (m) | $771.45K | $1.63M | (m) |
| 2012-12-31 | Reported | (m) | (m) | (m) | (m) | -20.09% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | Reported | -$919.72K* | -$1.02M | $97.32K* | (m) | (m) | $8.39K* | -$1.95M* | (m) | $573.56K | $1.44M | (m) |
| 2012-06-30 | Reported | -$365.49K* | -$479.53K | $114.04K* | (m) | (m) | $80.34K* | -$1.37M* | (m) | $486.02K | $1.80M | (m) |
| 2012-03-31 | Reported | (m) | (m) | (m) | (m) | -107.43% | $4.52K | -$1.88M | (m) | $689.67K | $1.34M | (m) |
| 2011-12-31 | Reported | (m) | (m) | (m) | (m) | -103.57% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | Reported | -$1.32M* | -$1.43M | $110.24K* | (m) | (m) | $14.92K* | -$1.32M* | (m) | $909.91K | $1.37M | (m) |
| 2011-06-30 | Reported | -$1.40M* | -$1.47M | $68.00K* | (m) | (m) | (m) | -$1.91M* | (m) | $1.06M | $1.11M | (m) |
| 2011-03-31 | Reported | -$1.64M* | -$1.71M | $70.96K | (m) | (m) | (m) | -$1.57M | (m) | $1.17M | $1.24M | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | (m) | (m) | (m) | -63.16% | $522.00K | -$23.90M | (m) | $13.90M | $16.50M | $55.00K |
| 2024-12-31 | Reported | (m) | (m) | (m) | (m) | -59.75% | $275.00K | -$8.95M | (m) | $12.39M | $11.99M | $12.00K |
| 2023-12-31 | Reported | (m) | (m) | (m) | (m) | -91.09% | $717.00K | -$13.72M | (m) | $11.71M | $11.76M | $8.00K |
| 2022-12-31 | Reported | (m) | (m) | (m) | (m) | -78.28% | $253.00K | -$16.17M | (m) | $10.89M | $9.61M | $0.00 |
| 2021-12-31 | Reported | (m) | (m) | (m) | (m) | -81.08% | $168.00K | -$12.70M | (m) | $9.28M | $8.00M | $0.00 |
| 2020-12-31 | Reported | (m) | (m) | (m) | (m) | -45.88% | $41.00K | -$7.81M | (m) | $4.69M | $5.27M | $0.00 |
| 2019-12-31 | Reported | (m) | (m) | (m) | (m) | -39.67% | $10.00K | -$2.85M | (m) | $2.81M | $4.30M | (m) |
| 2018-12-31 | Reported | (m) | (m) | (m) | (m) | -69.88% | $63.49K | -$4.63M | (m) | $2.31M | $4.33M | (m) |
| 2017-12-31 | Reported | (m) | (m) | (m) | (m) | -84.28% | $26.75K | -$5.99M | (m) | $2.81M | $4.05M | (m) |
| 2016-12-31 | Reported | (m) | (m) | (m) | (m) | -127.54% | $101.00K | -$5.82M | (m) | $2.63M | $4.19M | (m) |
| 2015-12-31 | Reported | (m) | (m) | (m) | (m) | -190.72% | $76.88K | (m) | (m) | $1.96M | $8.37M | (m) |
| 2014-12-31 | Reported | (m) | (m) | (m) | (m) | -137.14% | $48.13K | -$7.25M | (m) | $3.30M | $8.04M | $0.00 |
| 2013-12-31 | Reported | (m) | (m) | (m) | (m) | -179.33% | $74.47K | -$7.78M | (m) | $2.92M | $7.06M | $0.00 |
| 2012-12-31 | Reported | (m) | (m) | (m) | (m) | -53.62% | $127.45K | -$7.43M | (m) | $2.48M | $6.03M | $0.00 |
| 2011-12-31 | Reported | (m) | (m) | (m) | (m) | -145.79% | $26.10K | -$6.24M | (m) | $4.25M | $4.83M | (m) |
| 2010-12-31 | Reported | (m) | (m) | (m) | (m) | -346.48% | $61.70K | -$7.71M | (m) | $5.68M | $4.70M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |